ZA200110499B - Pharmaceutical composition. - Google Patents

Pharmaceutical composition.

Info

Publication number
ZA200110499B
ZA200110499B ZA200110499A ZA200110499A ZA200110499B ZA 200110499 B ZA200110499 B ZA 200110499B ZA 200110499 A ZA200110499 A ZA 200110499A ZA 200110499 A ZA200110499 A ZA 200110499A ZA 200110499 B ZA200110499 B ZA 200110499B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA200110499A
Inventor
Yusuf Khwaja Dr Hamied
Original Assignee
Cipla Medpro Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Medpro Pty Ltd filed Critical Cipla Medpro Pty Ltd
Priority to ZA200110499A priority Critical patent/ZA200110499B/en
Publication of ZA200110499B publication Critical patent/ZA200110499B/en

Links

ZA200110499A 2001-05-11 2001-12-21 Pharmaceutical composition. ZA200110499B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200110499A ZA200110499B (en) 2001-05-11 2001-12-21 Pharmaceutical composition.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200103831 2001-05-11
ZA200110499A ZA200110499B (en) 2001-05-11 2001-12-21 Pharmaceutical composition.

Publications (1)

Publication Number Publication Date
ZA200110499B true ZA200110499B (en) 2002-04-03

Family

ID=27145569

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200110499A ZA200110499B (en) 2001-05-11 2001-12-21 Pharmaceutical composition.

Country Status (1)

Country Link
ZA (1) ZA200110499B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325404B2 (en) * 2005-12-14 2012-03-01 Cipla Limited Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006325404B2 (en) * 2005-12-14 2012-03-01 Cipla Limited Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit

Similar Documents

Publication Publication Date Title
EP1450824A4 (en) Pharmaceutical composition
ZA200003998B (en) Pharmaceutical compositions.
MXPA03000771A (en) New pharmaceutical composition.
MXPA03007215A (en) Pharmaceutical formulations.
MXPA03006775A (en) Pharmaceutical formulation.
MXPA03007093A (en) New composition.
MXPA03007641A (en) Pharmaceutical formulation.
AP2003002907A0 (en) Liquid pharmaceutical composition.
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
PL366510A1 (en) Pharmaceutical combinations
ZA200210359B (en) Pharmaceutical compositions.
MXPA03009698A (en) Novel composition.
MXPA03007693A (en) Composition.
EP1408896A4 (en) Pharmaceutical composition
GB0129117D0 (en) Pharmaceutical composition
MXPA03002105A (en) Pharmaceutical compositions.
EG23378A (en) Composition.
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
MXPA03008077A (en) Composition.
ZA200110500B (en) Pharmaceutical composition.
MXPA03005965A (en) Pharmaceutical composition containing citalopram.
MXPA03007318A (en) Pharmaceutical composition.